Although the immune response gene-set is differentially expressed in the same direction in all ESR1-negative BRCA1 tumours examined here, it can stratify tumours in at least two additional subclasses (Figure 3a and b) depending on the magnitude of the expression of specific genes (Supplementary Table S5). This evidence concerns the gene ESR1 and neoplasm.